InvestorsHub Logo

Amatuer17

10/26/20 6:24 AM

#126187 RE: All-Bidness #126185

“Leronlimab Shows Early, but Promising Clinical Responses in First Two Patients Recovering from Stroke”

This is an interesting area - quite new and very promising.

The key is - when Lero needs to be given after stroke? Is it immediately to reduce the actual damage after stroke or even after 1 to 2 days after actual stroke it can be useful?

This has huge potential as a therapeutic area - the trial timeline could also be shorter.

Latane

10/26/20 8:07 AM

#126201 RE: All-Bidness #126185

This is awesome and all good and well, but we need to focus. Get an approval...any approval so you can generate revenue and raise capital to do all these other studies. If we keep casting nets and don’t focus on the fish already on the line, we are going to end up with a R/S and or go BK. Pay to enroll the 63 and do it now!